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Abstract
 
The work aims at developing a strategy for the identification of potent drug 
target by analyzing signaling pathways. The strategy developed is designed 
and tested in concern with Toll Like Receptor
TLR4 pathway is a major pathway which get trigger against Lipo
polysaccheride (LPS) stimulus. The work describes a strategy to identify 
potent drug targets by understanding the flow of information in signaling 
pathways by representing them in the form of stoichiometric matrices and 
analyzing mathematically by adopting relatively successful approaches, 
including flux balance analysis (FBA), Single Value Decomposition (SVD). The 
strategy successfully proposes TNF-α Receptor Associated Factor





Fundamental cell processes would be driven 
by intercellular and intracellular communication 
via direct contact or soluble factors like hormones 
or cytokines. Environmental signals received by 
membrane molecules called receptors, which 
induce cascade of biochemical reactions in cell 
cytoplasm and nucleus (Alberts and Johnson, 
2002). In effect, usually the expression level of 
target genes has altered, that corresponds to cell 
response to the input stimuli. The intracellular 
reactions occur between biomolecule
fixed, in a timescale of single signal processing, 
set of reaction channels. Cell response has 
determined by transient dynamics of such 
interactions network by pathway engineering 
(Rowinsky, 2003).  
 
Pathway engineering is to optimize pathway 
networks to reveal and understand the signal flow 
in networks. To reach this goal, quantification of 
the pathway network is necessary, to quantify 
there is a need to measure the fluxes in the 
pathway network. Many high throughput 
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mechanisms. Main drawback of the high 
throughput biological experiments is its results 
data bias and detailed inquiring into specific 
interactions or their kinetic data (Cho and Labow, 
2006). Scientific computing and mathematical 
modeling of such molecular, signal processing 
pathways is very beneficial in acquiring system 
level understanding about dynamical 
mechanisms of cell (Butcher and Berg, 2004).
 
In that connection several modeling 
approaches have been used over recent years to
analyze complex biological systems such as 
signaling pathways, ranging from traditional 
mathematical methods based on differential 
equations to computational methods based on 
stochastic simulation and model checking (Regev 
et al., 2001). 
 
Although there are a variety of metabolic 
modeling approaches, all of them share a 
fundamental requirement: a stoichiometric matrix 
based on a reconstructed metabolic network. 
Each column of the stoichiometric matrix 
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corresponds to a chemical or transport reaction, 
with non-zero values that identify the metabolites 
which participate in the reaction as well as the 
stoichiometric coefficients that correspond to 
each metabolite. The matrix also contains 
directionality: substrate and product metabolites 
in the matrix have negative and positive 
coefficients, respectively. By considering the 
matrix rows instead of the columns, the 
stoichiometric matrix can also be thought as the 
list of reactions in which a given metabolite 
participates. This interpretation is useful while 
defining mass balances for each metabolite in the 
network. 
 
Metabolic Flux Balance Analysis (FBA) is one 
such a method for analyzing the flow of 
metabolites through a metabolic network (Covert 
et al., 2001). It is a mathematical method for 
analyzing metabolism. It is a direct application of 
linear programming to biological systems that 
uses the stoichiometric coefficients for each 
reaction in the system as the set of constraints for 
the optimization. Additionally, this method 
requires the assumption of biological steady state 
(Covert and Palsson, 2003). Imposing this 
restriction allows the assumption that at any 
given time the concentration of a given 
compound in the metabolic network is constant 
(Covert et al., 2001). 
 
Except in some modified forms, FBA does not 
account for regulatory effects such as activation 
of enzymes by protein kinases or regulation of 
gene expression. In that regard, the current study 
proposes a model to predict potential drug target 
for LPS neutralization by considering regulatory 
effects in signaling as reactions and the study 
focuses on the concept of signal crosstalk or 
cancelation observed in signaling cascades to 
identify the potent drug target by adopting SVD 
method.  
 
MATERIALS AND METHODS 
Pathway Retrieval and Analysis 
For the representation of a flux there is a need 
to visualize and understand the pathway, this has 
achieved by the retrieval of TLR4 pathway from 
the pathway database PANTHER 
(http://www.pantherdb.org/pathway/) in *.SBML 
(System Biology Markup Language) format. Cell 
Designer V3.0 has used for Analysis and 
reconstruction of pathway (Bornstein and 
Keating, 2008). 
Pathway Network Construction 
Signals in a pathway are represented with the 
help of signaling network. The most important 
assumption made for the FBA is that the model 
will be in a steady state. The steady state of 
signaling networks can be described in terms of 
mass balance equations. These equations 
describe the change of signal flux over time, 
based on the fluxes through the signaling 
network. The internal fluxes are represented by 
“v” and the external fluxes are represented by “b”. 
The signals in TLR pathway were identified and 
pathway network is constructed, the mass 
balance for is represented with the help of 
stoichiometric matrix S with the flux vector V. 
Stoichiometric Matrix Construction 
A stoichiometric matrix S is an m*n, where m 
corresponds to the number of genes and n is the 
number of chemical reactions or fluxes taking 
place within the metabolic network. The vector v 
corresponds to the quantity of fluxes within the 
signaling network. It also describes the rate at 
which the gene is chemically signaling to the 
gene at downstream. The fluxes, which enter the 
gene instances, were considered positive and the 
fluxes that leave the genes are considered 
negative. In the study, for simplification, the 
fluxes are considered to be either “1” (Signal 
input) or “-1” (Signal output). Optimization of the 
stoichiometric matrix was done to optimize the 
metabolic network by which a potent drug target 
for LPS neutralization can be identified. Singular 
Value Decomposition (SVD) has conducted to 
identify the dependent Extreme paths in the 
network usin MATLAB. 
SVD Using MATLAB 
Mass balance equations are represented as 
linear equations. The null spaces need to be 
obtained which is a set of operands which solves  
                    S.v= 0  (Orth et al., 2010) 
This can be determined by employing SVD 
method. MATLAB is a programming environment 
for algorithm development, data analysis, 
visualization, and numerical computation. The 
following coding is used to optimize the 
stoichiometric matrix: 
Algorithm for the execution of SVD for the derived 
matrix: 
1. Input matrix values, Matrix_name = X. 
2. Calculate the matrix by calling rank() and 
assign the value to the variable R. 
3. Derive SVD by calling svd() and assign values 
to the matrices U,S and V respectively. 
4. Derive BETA, the final vector matrix by calling 
null (Matrix_name,’r’). 
5. The graphs are plotted by using code 
Plot(Matrix_name). 





The TLR pathway is retrieved from PANTHER 
pathway database and critically analyzed by 








Figure 1: TLR4 signaling pathway visualized using Cell Designer. 
Bharath et al.,    
 
The stoichiometric matrix S1 is derived for 
TLR4 pathway shown in Figure 2A 
reconstructed pathway model is shown in Figure 
2B by considering flux incoming as 1, no reaction 
Figure 2: TLR4 pathway (A) 
.
 Stoichiometric Matrix-1 (S1) 
dA/dt= -b1  
dB/dt=  b1-b2 
dC/dt= b2-V1-V2 





dI/dt= V8- V9 – V10 - V11 
dJ/dt= V9 – V12 – V15 














Figure 3: Representation of S1 in the form of graph, here 27 vectors (2 extrinsic and 25 intrinsic) are 
taken horizontally. Each vector touches 
reactions respectively.  
    Sci. technol. arts Res. J., Jan-Mar 2013,
accordingly 
as 0 and outgoing flux as -1. The stoichiometric 
matrix-1 (S1) holds the information of TLR4 
pathway mathematically. 
Pathway network, (B) Reconstructed pathway model
dL/dt= V12 – V13 
dM/dt= V15 – V16 
dN/dt= V11 – V20  
dO/dt= V10 – V22 
dP/dt= V13 – V14 
dQ/dt= V16 – V17 
dR/dt= V17 – V18 
dS/dt= V18 – V19 
dT/dt= V20 – V21 
dU/dt= V22 – V23 
dV/dt= V19+ V21+ V23 - V24
-1, 0 and 1 for outgoing, no reaction and incoming 
 2(1): 50-55 
53 
. 
















Figure 4: Representation of matrix V after SVD in the form of graph, here 27 vectors (2 extrinsic and 25 
intrinsic) are taken horizontally. Each vector shows their flux level in pathway network, Node V 
and Node H shares least flux -0.59 (blue line)and -0.75 (green line) respectively.  
 
DISCUSSION 
Drug currently used in the market to treat 
many diseases have limited therapeutic value 
due to the failure in identifying a best therapeutic 
drug targets. The target identification needs the 
proper understanding of the pathways involved in 
disease. Rapidly increasing number of revealed 
biological pathways calls for the development and 
use of simulation methods and tools that would 
facilitate their analysis & virtual experimentation. 
Metabolic network reconstruction and 
simulation allows for an in depth insight into 
comprehending the molecular mechanisms of a 
particular organism, especially correlating 
the genome with molecular physiology. 
 
In that concern the present work contributes 
as a novel interdisciplinary approach for the 
representation of engineered models in a 
consistent format and further simulating them in 
silico, for the drug target identification, 
standardization and model formalism. Here the 
knowledge on signaling pathways involved in 
TLR4 pathway is downloaded from the 
PANTHER pathway database and critically 
analyzed by employing the pathway visualization 
tool Cell Designer V3.0 as shown in Figure 1. A 
closer assessment of pathways revealed that 
signaling pathways interact with each other, 
forming a network. Complexity in pathway 
network is reduced and common genes were 
identified in order to reveal the role of all the 
potential paths in signaling pathway for crosstalk. 
Few genes, which can contribute for the 
signaling, were manually curated and added 
using the Cell Designer V3.0. 
 
The critical analysis of pathways encouraged 
us to design the pathway networks as shown in 
Figure 2A. The initial biological pathway models 
are reconstructed as pathway models to reduce 
the complexity. Pathway models are constructed 
by assuming every nodes in signal as English 
alphabets, internal reactions as Vi and external 
reactions as bi as given in the Figure 2B. These 
pathway models facilitated the construction of 
stoichimetric matrix of TLR4 pathway with 23 
rows and 27 columns having rank of matrix 22.   
 
The stoichimetric matrix is subjected for the 
SVD analysis for the identification of extreme 
pathways. SVD method derived the extreme 
pathways for S1 with 23 rows and 23 columns. In 
the derived matrix node H and node V shared 
least flux value of -0.59 and -0.75 respectively, 
this very clearly indicates that node H and node V 
consisting of more outgoing reactions in all 
possible extreme paths when compare with other 
nodes in the same pathway. The cross 
verification for nodes H and V through the original 
pathway found matched with TRAF6 and AP1, it 
clearly reveals TRAF6 and AP1 can act as 
probable drug targets. Since AP1 is a nuclear 
factor which has the accessibility into nuclear 
membrane it found risky to consider it as the drug 
target, thus TRAF6 can be strongly proposed as 
potent drug target for LPS neutralization. The 
identified drug target is validated by manual text 
mining method; the earlier investigators also 
reported TRAF6 as a potent drug target for LPS 
neutralization.





The method proposed in the study found 
reliable for all the pathways to identify a potent 
drug target. Degree of error in the method 
depends on sensitivity of pathway construction, 
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